Baird Medical Investment Holdings Limited (BDMD) vs Scilex Holding Company (SCLX)
A side-by-side comparison of Baird Medical Investment Holdings Limited and Scilex Holding Company across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BDMD
Baird Medical Investment Holdings Limited
$0.78HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
SCLX
Scilex Holding Company
$3.96HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — BDMD vs SCLX
growth of $100 · dividends reinvested · last 5yBDMD -92.3% (-40.1%/yr)SCLX -98.9% (-59.5%/yr)BDMD compounded faster over this window
Log scale — wide-divergence pair
BDMD SCLX
BDMD vs SCLX: by the numbers
- •SCLX is the larger company ($34M vs $33M market cap).
- •Both run net losses; BDMD's is the smaller (-121.04% vs -1414.57% net margin).
- •BDMD grew revenue faster over the past five years (4.46% vs 3.58% CAGR).
Metrics side by side
Valuation
| Metric | BDMD | SCLX |
|---|---|---|
| Forward P/E | 9.75 | N/A |
| P/S ratio | N/A | 1.06 |
| P/B ratio | 0.95 | N/A |
Profitability
| Metric | BDMD | SCLX |
|---|---|---|
| Gross margin | 83.79% | 49.68% |
| Operating margin | -113.31% | -903.52% |
| Net margin | -121.04% | -1414.57% |
| ROE | -86.96% | N/A |
| ROIC | -50.66% | N/A |
Growth (annualized)
| Metric | BDMD | SCLX |
|---|---|---|
| Revenue CAGR (5Y) | 4.46% | 3.58% |
| Total return CAGR (5Y) | N/A | -59.50% |
Frequently asked
- Which has grown faster, BDMD or SCLX?
- Over the past five years, BDMD grew revenue faster — BDMD at a 4.46% CAGR versus SCLX at 3.58%.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.